✦ LIBER ✦

640 POSTER Phase I study of ispinesib (SB-715992), a kinesin spindle protein inhibitor, in combination with capecitabine in patients with advanced solid tumors

✍ Scribed by J. Rodon; E. Till; A. Patnaik; C. Takimoto; M. Beeram; D. Williams; C. Bowen; J. Hodge; M. Dar; A. Toclher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of ispinesib, a kinesin

✍ Blagden, S P; Molife, L R; Seebaran, A; Payne, M; Reid, A H M; Protheroe, A S; V 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

98 POSTER A Phase I study of sorafenib i

✍ A. Awada; T. Gil; K. Burk; J. Vanhamme; I. Mancini; T. Besse; E. Brendel; A. Mat 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A phase I trial of MK-0731, a Kinesin Sp

✍ Kyle Holen, Robert DiPaola, Glenn Liu, Antoinette R. Tan, George Wilding, Karl H 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 242 KB

714 POSTER Phase I tolerability/safety o

✍ C. Verschraegen; C. Sweeney; G. Chiorean; F.C. Lee; S. Jones; L. Tye; A. Bello; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Tesetaxel, a new oral taxane, in combina

✍ Muhammad Wasif Saif; John Sarantopoulos; Amita Patnaik; Anthony W. Tolcher; Chri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

A phase I study of Triapine®in combinati

✍ William R. Schelman; Sherry Morgan-Meadows; Rebecca Marnocha; Fred Lee; Jens Eic 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 364 KB